Halberd Corporation (HALB)

0.0085 +0.0001 (+1.19%) At close: 03:00PM EDT

Halberd Corporation

PO Box 25
Jackson Center, PA 16133
United States
814 786 8849
https://halberdcorporation.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. William A. Hartman	President, CEO & Chairman	N/A	N/A	1942
Mr. John S. Borza AVS, MBA, PE	COO & Director	N/A	N/A	1954
Ms. Heidi H. Carl	Director & Accounting Director	N/A	N/A	1971
Dr. Mitchell S. Felder M.D.	CTO & Member of the Scientific Advisory Board	N/A	N/A	1954
Dr. Patricio F. Reyes FAAN, M.D.	Chief Mechanical Officer & Member of the Scientific Advisory Board	N/A	N/A	1947

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.

Corporate Governance

Halberd Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.